DelveInsight's Minimal Residual Disease Testing Market Insights report provides the current and forecast market analysis, individual leading minimal residual disease testing companies' market shares, ...

Notably, data illustrating the prognostic value of clonoSEQ MRD assessment using peripheral blood in MM and from circulating tumor DNA (ctDNA) in DLBCL will also be presented.

In an analysis of data from the CLL14 study (n=337), patients with undetectable MRD in blood by clonoSEQ at three months post-treatment had a nearly seven-fold reduced risk of disease progression ...

The positive predictive value (PPV) of MRD detection was 100% and 90.9% at the landmark and longitudinal time points, respectively, indicating a high risk of recurrence for patients with positive MRD.

Molecular residual disease (MRD) has grown in importance as an oncological biomarker1. | Advanced ctDNA analysis yields biomarkers of cancer dynamics essential in therapeutic monitoring ...

Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have a relapse despite having a measurable residual disease (MRD)–negative complete remission with combination ...

Minimal residual disease (MRD) could be used to predict which patients with classical Hodgkin lymphoma (cHL) will relapse after autologous stem cell transplantation (ASCT), according to an ...

Over the last decade, molecular residual disease (or minimal residual disease; MRD) has emerged as a powerful dynamic biomarker in oncology. | If you’re in translational research, you know how ...

There are also disparities in how MRD is communicated and understood across different hematologic diseases. For patients with ALL or AML, MRD status can dictate eligibility for transplants, trials ...

Testing for minimal residual disease (MRD) is increasingly being used in patients with cancer because deep MRD negativity (MRD—) is associated with better outcomes for patients and MRD status ...

Melcor Developments Ltd. Annual stock financials by MarketWatch. View the latest MRD financial statements, income statements and financial ratios.